ARCHIVES

CHOP Evolution Remains Touchy Issues; Contractors Say NCI Plan Too Burdensome

This article is from The Cancer Letter archive.

Vol. 09 No. 16 | April 22, 1983

Download PDF Visit The Full Archive

Related Articles

FDA News< Regulations To Ease For Advertising Drugs On TV, Radio

September 12, 1997

NCI Plans Progress Review In Lymphoma This Year.

March 10, 2000

In Brief: GM Cancer Research Foundation Awards Three Prizes to Five Cancer Researchers

May 5, 2000

NCI-Approved Trials Listed

March 30, 2007

Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment.

July 30, 2004

EPIC, PLCO Studies Show High Fiber Diet Cuts Cancer Risk

May 2, 2003